Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-22T16:37:31.308Z Has data issue: false hasContentIssue false
  • English
  • Français

Immunogenicity of experimental trachoma vaccines in baboons: III. Experiments with inactivated vaccines

Published online by Cambridge University Press:  15 May 2009

L. H. Collier ,
W. A. Blyth ,
N. M. Larin  and
J. Treharne
L. H. Collier
Affiliation:
M.R.C. Trachoma Research Unit, The Lister Institute of Preventive Medicine, London, S.W. 1
W. A. Blyth
Affiliation:
M.R.C. Trachoma Research Unit, The Lister Institute of Preventive Medicine, London, S.W. 1
N. M. Larin
Affiliation:
Virology Department, Therapeutics Research Division, Pfizer Ltd., Sandwich, Kent
J. Treharne
Affiliation:
Virology Department, Therapeutics Research Division, Pfizer Ltd., Sandwich, Kent
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Heating at 37° C. for 5 days completely abolished the capacity of a trachoma/inclusion conjunctivitis (TRIC) vaccine to protect baboons against conjunctival infection. Treatment with formalin also impaired or abolished immunogenicity.

The rate of inactivation of TRIC agent by ultraviolet light was exponential, and was about 7 times faster than that of a suspension of vaccinia virus of comparable turbidity. By contrast with vaccinia, irradiation of TRIC agent with twice the dose of ultraviolet light needed to destroy infectivity resulted in loss of immunogenicity.

The deleterious action of these inactivation procedures on the potency of TRIC vaccines may be explained in terms of damage to a protective antigen; alternatively, live vaccines may be more immunogenic because TRIC agents are capable of multiplying within primate hosts after parenteral injection.

Unlike the same type of variant of another strain of inclusion conjunctivitis, the ‘fast-killing’ variant of MRC-4 was still pathogenic for the baboon conjunctiva.

Type
Research Article
Information
Journal of Hygiene , Volume 65 , Issue 1 , March 1967 , pp. 97 - 107
Copyright
Copyright © Cambridge University Press 1967

References

Bietti, G. B., Guerra, P., Felici, A. & Vozza, R. (1962). Research studies on trachoma. Acta Soc. ophthal. jap. 66, 362.Google Scholar
Bradstreet, C. M. P. & Taylor, C. E. D. (1962). Technique of complement-fixation test applicable to the diagnosis of virus diseases. Mon. Bull. Minist. Hlth 21, 96.Google Scholar
Collier, L. H. (1955). The development of a stable smallpox vaccine. J. Hyg., Camb. 53, 76.CrossRefGoogle ScholarPubMed
Collier, L. H. (1961). Experiments with trachoma vaccines; experimental system using inclusion blennorrhoea virus. Lancet, i, 795.CrossRefGoogle Scholar
Collier, L. H. (1962). Experimental infection of baboons with inclusion blennorrhoea and trachoma. Ann. N.Y. Acad. Sci. 98, 188.CrossRefGoogle ScholarPubMed
Collier, L. H. (1966). The present status of trachoma vaccination studies. Bull. Wld Hlth Org. 34, 233.Google ScholarPubMed
Collier, L. H. & Blyth, W. A. (1966 a). Immunogenicity of experimental trachoma vaccines in baboons. I. Experimental methods, and preliminary tests with vaccines prepared in chick embryos and in HeLa cells. J. Hyg., Camb. 64, 513.Google ScholarPubMed
Collier, L. H. & Blyth, W. A. (1966 b). Immunogenicity of experimental trachoma vaccines in baboons. II. Experiments with adjuvants, and tests of cross-protection. J. Hyg., Camb. 64, 529.Google ScholarPubMed
Collier, L. H., McClean, D. & Vallet, L. (1955). The antigenicity of ultra-violet irradiated vaccinia virus. J. Hyg., Camb. 53, 513.Google ScholarPubMed
Collier, L. H. & Smith, A. (1967). Dissemination and immunogenicity of live TRIC agent in baboons after parenteral injection. Am. J. Ophthal. (In the Press.)CrossRefGoogle ScholarPubMed
Furness, G., Graham, D. M. & Reeve, P. (1960). The titration of trachoma and inclusion blennorrhoea viruses in cell cultures. J. gen. Microbiol. 23, 613.CrossRefGoogle ScholarPubMed
Grayston, J. T., Woolridge, R. L., Wang, S. P., Yen, C. H., Yang, C. Y., Cheng, K. H. & Chang, I. H. (1963). Field studies of protection from infection by experimental trachoma virus vaccine in preschool-aged children on Taiwan. Proc. Soc. exp. Biol. Med. 112, 589.CrossRefGoogle ScholarPubMed
Habel, K. & Sockhider, B. T. (1947). A continuous flow method of exposing antigens to ultra-violet irradiation. J. Immun. 56, 273.CrossRefGoogle Scholar
Jones, B. R. (1961). TRIC virus infections in London. Trans. ophthal. Soc. U.K. 81, 367.Google Scholar
Jones, B. R. & Collier, L. H. (1962). Inoculation of man with inclusion blennorrhea virus Ann. N.Y. Acad. Sci. 98, 212.CrossRefGoogle Scholar
Macfadyen, D. A. (1945). Estimation of formaldehyde in biological mixtures. J. biol. Chem. 158, 107.CrossRefGoogle Scholar
Reeve, P. & Taverne, J. (1963). Observations on the growth of trachoma and inclusion blennorrhoea virus in embryonate eggs. J. Hyg., Camb. 61, 67.CrossRefGoogle Scholar
Snyder, J. C., Nichols, R. L., Bell, S. D., Haddad, N. A., Murray, E. S. & McComb, D. E. (1964). Vaccination against trachoma in Saudi Arabia: design of field trials and initial results. Industry trop. Hlth 5, 65.Google Scholar
Wang, S. P., Kenny, G. E. & Grayston, J. T. (1967). Characterization of trachoma antigen protective against mouse toxicity. Am. J. Ophthal. (In the Press.)CrossRefGoogle ScholarPubMed